FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 29

Author

Admin 425 posts 0 comments

Articles

Unlocking the Next-Level of Fast Disbursements

Admin May 5, 2025
We live in a world where time and speed are of the essence. Fast payments have become ubiquitous across several…
Articles

Understanding the Importance of Credit Scores in Personal Finance

Admin May 2, 2025
In today’s financial world, your credit score is more than just a number—it’s a powerful tool that affects…
Articles

Capital Management in the B2B Industry: A Strategic Approach to Financial…

Admin Apr 30, 2025
In the fast-paced and competitive landscape of Business-to-Business (B2B) industries, effective capital…
Articles

What’s Going On in the Fintech Industry?

Admin Apr 29, 2025
The fintech industry is evolving rapidly, driven by innovation, regulation, and growing consumer demand…
Featured News

Strategic Storage Trust VI Completes Loan Refinancing

Admin Apr 28, 2025
Strategic Storage Trust VI, Inc. (SST VI), a self-storage-focused real estate investment trust (REIT), has…
Webinar

Webinar | 1 May 2025 | Banking on agentic AI: The future of autonomous financial…

Admin Apr 25, 2025
Date: Thursday, 1 May 2025 Time: 2:00 PM BST | 09:00 AM EDT Agentic AI is poised to transform financial…
Featured News

ATEC Announces 2024 Financial Results and 2025 Growth Outlook

Admin Apr 24, 2025
Alphatec Holdings (ATEC) Reports Robust 2024 Financial Results and Projects Strong Growth for 2025 CARLSBAD,…
Articles

The Rise of Digital Lending: How Fintech is Revolutionizing Borrowing

Admin Apr 23, 2025
In today’s fast-paced digital economy, traditional loan processes—filled with paperwork, long approval…
Whitepaper

Empowering Instant Credit Through Open Banking

Admin Apr 17, 2025
The global consumer finance market has rebounded at pace from the turbulence of the pandemic, led by an…
Whitepaper

Innovating through platforms and ecosystems

Admin Apr 16, 2025
Many traditional financial services products are being commoditized. They are becoming irrelevant in the lives of…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Future of Finance: Review on the outlook for the UK financial system
    • FinTech and Employee F&F Settlement: How Digital Financial Platforms Are Transforming the Employee Exit Process
    • How AI and Digital Innovation Are Transforming the Future of the FinTech Industry
    • The Power of Ecosystems for Banking
    • The Rise of Fintech: Transforming the Financial Landscape

    ARTICLE

    FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies
    2026-08-13T18:59:23Z
    Silver Spring, MD, Aug. 13, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Simparica TRIO (​sarolaner, moxidectin, and pyrantel chewable...


    The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech
    2026-08-13T18:31:16Z
    Stunning Brain-Cancer Data Are Putting NeOnc’s Nose-to-Brain Delivery Platform, and Its Broader Potential, Front and Center


    ATHENS ORTHOPEDIC CLINIC REINTRODUCES ORTHOPEDIC URGENT CARE NETWORK UNDER AOC ORTHONOW
    2026-08-13T17:50:25Z
    New Network Gives Patients a More Accessible, Cost-Effective Alternative for Orthopedic Injuries in Loganville, Athens and Lake Oconee


    Sanofi: Information concerning the total number of voting rights and shares - July 2026
    2026-08-13T16:34:47Z
    Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of...


    City of Mobile proclaims Project Persevere Day as The Helios Alliance Reports 117,444 Services Delivered in First Year of Opioid Abatement Program
    2026-08-13T16:15:00Z
    Sixteen organizations delivered 117,444 services at $143.81 per person — among the most efficient deployments of opioid settlement funds nationally — as a public awareness campaign prepares to launch


    Aligned Marketplace Raises $20 Million, Achieves Measurable Outcomes with Large Employers
    2026-08-13T16:00:00Z
    A Third-Party Validated 12 Percent Reduction in Total Cost of Care Delivered in Year One For A Large Fortune 500 Company Proves the Independent Primary Care Model Works at Scale


    Valneva Half-Year 2026 Financial Report
    2026-08-13T15:45:00Z
    Valneva Half-Year 2026 Financial Report


    WellBridge Surgical Named No. 988 on the 2026 Inc. 5000 List, the Most Prestigious Ranking of America’s Fastest-Growing Private Companies
    2026-08-13T15:11:46Z
    Following Significant Revenue Growth Over the Past Three Years, Earning a Place Among the Nation’s Most Successful Independent Businesses


    Tiny Health Named No. 208 on the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies
    2026-08-13T15:03:13Z
    Microbiome Innovator Recognized for 1,624% Three-Year Revenue Growth, Earning a Place Among the Nation’s Most Successful Independent Businesses


    Invitation to the presentation of ALK’s first six months (Q2) 2026 results on Thursday, 20 August 2026
    2026-08-13T14:06:44Z
    ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) will publish its results for the first six months of 2026 in the morning on Thursday, 20 August 2026.


    Early-Bird Deadline Approaches for 2nd Annual Guardian Initiative Charity Golf Tournament as Veterans Seek Sponsors to Play
    2026-08-13T14:00:00Z
    Players have until August 28 to take advantage of early-bird pricing for the September 28 charity tournament at Maderas Golf Club, while local veterans are seeking sponsors for the opportunity...


    Arisan Therapeutics Selected for NIAID Contract Award to Develop a Therapeutic Small Molecule Viral Entry Inhibitor as a Medical Countermeasure for Filovirus Infection
    2026-08-13T14:00:00Z
    Contract Valued at Up to $24 million Supports IND-Enabling Studies for Arisan’s Lead Candidate with Demonstrated Activity Against Multiple Ebolaviruses


    New MotherToBaby Study Targets Pregnancy Data Gap for Newer Eczema Treatment
    2026-08-13T13:55:00Z
    The FDA has determined that human pregnancy data for Ebglyss® remain insufficient. By enrolling U.S. and Canadian participants, this study will help generate the evidence needed to inform future treatment...


    Acentra Health Awarded Five-Year Contract Extension to Continue Utilization Management Services in Colorado
    2026-08-13T13:33:00Z
    Contract allows state to promote quality and cost-effective healthcare for 1.3 million Coloradans


    Meet Pomoni: Physician-Founded Polyphenol Brand Unveils New Name, New Olive Oil Supplement for Athletes
    2026-08-13T13:15:00Z
    Pomoni debuts Phenolia Endurance,Sponsors Iowa City's core4 Gravel Earth Series race


    OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
    2026-08-13T13:15:00Z
    Transaction provides additional non-dilutive capital and enhanced financial flexibility while preserving meaningful long-term royalty upside


    MapLight Therapeutics Announces $150 Million Private Placement Financing 
    2026-08-13T13:10:00Z
    SAN FRANCISCO and BOSTON, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central...


    CurePSP Establishes Public Policy and Advocacy Team to Accelerate National Impact
    2026-08-13T13:00:00Z
    NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- CurePSP has formally established its Public Policy and Advocacy team with the recent additions of Nora Wong, MPH, Associate Director of Public...


    Opción Yo Earns a Place Among the Top 3% of the Inc. 5000
    2026-08-13T12:51:07Z
    MIAMI, FL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- — This recognition reflects a profound cultural shift as more people prioritize emotional well-being with the same intention they have long invested...


    Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth
    2026-08-13T12:51:00Z
    WOBURN, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT) in...


    SS Innovations Reports Second Quarter 2026 Financial Results
    2026-08-13T12:30:00Z
    Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales


    Dogwood Therapeutics Announces Second Quarter 2026 Financial Results
    2026-08-13T12:30:00Z
    - Halneuron® Phase 2b trial in Chemotherapy Induced Neuropathy on track for top-line results in fall 2026, 217 patients enrolled –


    PDS Biotech Reports Second Quarter 2026 Financial Results
    2026-08-13T12:30:00Z
    PRINCETON, N.J., Aug. 13, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage biotechnology company focused on developing targeted immunotherapies for cancer, today...


    Fate Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
    2026-08-13T12:30:00Z
    First lupus nephritis patient dosed in RECLAIM-LN, a Phase 2 potentially registrational trial utilizing FT819, an iPSC-derived, off-the-shelf CAR T-cell therapy; patient was treated as an outpatient with same-day discharge


    Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
    2026-08-13T12:30:00Z
    NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant unmet need, today...


    Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness
    2026-08-13T12:30:00Z
    Cash and Cash Equivalents of $28.4 Million as of June 30, 2026 Providing Runway Through Mid-2027; Company Advances Chemistry, Manufacturing and Controls (CMC) Work Toward NDA Resubmission


    Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
    2026-08-13T12:05:00Z
    NEEDHAM, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve outcomes for...


    WallabyPhenox Announces First Patient Enrolled in PROMISE Study Evaluating Treatment of Medium Vessel Occlusion Stroke
    2026-08-13T12:00:00Z
    IRVINE, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- WallabyPhenox today announced that the first patient has been enrolled in PROMISE (PROspective study on Management of Ischemic Stroke secondary to mEvo),...


    Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results
    2026-08-13T12:00:00Z
    Clinical and Scientific Progress Across the Pipeline Supports Multiple Upcoming Milestones


    Eupraxia Pharmaceuticals Reports Symptom Response Data from its Ongoing Phase 1b/2a RESOLVE Trial, Including New Data on Odynophagia (Painful Swallowing) in Eosinophilic Esophagitis Patients
    2026-08-13T12:00:00Z
    VANCOUVER, British Columbia, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.